Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Stoke Therapeutics Inc (NASDAQ: STOK)

 
STOK Technical Analysis
4
As on 9th Jun 2023 STOK STOCK Price closed @ 11.76 and we RECOMMEND Sell for LONG-TERM with Stoploss of 16.41 & Strong Sell for SHORT-TERM with Stoploss of 19.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

STOKSTOCK Price

Open 12.71 Change Price %
High 12.71 1 Day -0.93 -7.33
Low 11.68 1 Week 0.56 5.00
Close 11.76 1 Month 3.02 34.55
Volume 150000 1 Year -8.62 -42.30
52 Week High 26.10 | 52 Week Low 7.07
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
STOK
Daily Charts		 STOK
Intraday Charts		 Whats New @
Bazaartrend		 STOK
Free Analysis
 
STOK Important Levels Intraday
RESISTANCE13.74
RESISTANCE13.11
RESISTANCE12.71
RESISTANCE12.32
SUPPORT11.20
SUPPORT10.81
SUPPORT10.41
SUPPORT9.78
 
STOK Forecast May 2024
Share
4th UP Forecast20.87
3rd UP Forecast17.95
2nd UP Forecast16.14
1st UP Forecast14.34
1st DOWN Forecast9.18
2nd DOWN Forecast7.38
3rd DOWN Forecast5.57
4th DOWN Forecast2.65
 
STOK Weekly Forecast
4th UP Forecast19.29
3rd UP Forecast16.88
2nd UP Forecast15.38
1st UP Forecast13.89
1st DOWN Forecast9.63
2nd DOWN Forecast8.14
3rd DOWN Forecast6.64
4th DOWN Forecast4.23
 
STOK Forecast2024
4th UP Forecast49.76
3rd UP Forecast37.57
2nd UP Forecast30.04
1st UP Forecast22.51
1st DOWN Forecast1.01
2nd DOWN Forecast-6.52
3rd DOWN Forecast-14.05
4th DOWN Forecast-26.24
 
 
STOK Other Details
Segment EQ
Market Capital 873893632.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
STOK Address
STOK
 
STOK Latest News
 
Your Comments and Response on Stoke Therapeutics Inc
 
STOK Business Profile
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary ribonucleic acid therapeutics platform, Targeted Augmentation of Nuclear Gene Output (TANGO), to design ASOs to upregulate the expression of protein by individual genes in a patient. Its lead product candidate is STK-001 that is used to treat Dravet syndrome, a severe and progressive genetic epilepsy. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts. Address: 45 Wiggins Avenue, Bedford, MA, United States, 01730
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service